albendazole has been researched along with Leukemia, Prolymphocytic, T-Cell in 1 studies
Leukemia, Prolymphocytic, T-Cell: A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamet, D | 1 |
| Quinio, D | 1 |
| Moalic, E | 1 |
| Ianotto, JC | 1 |
| Dalbies, F | 1 |
| Guillerm, G | 1 |
| Marion, V | 1 |
| Berthou, C | 1 |
| Nevez, G | 1 |
1 other study available for albendazole and Leukemia, Prolymphocytic, T-Cell
| Article | Year |
|---|---|
[Systemic microsporidiosis and toxoplasmosis in a patient with T prolymphocytic leukemia].
Topics: Aged; Albendazole; Animals; Bone Marrow; Encephalitozoon; Encephalitozoonosis; Feces; Female; Humans | 2009 |